Marco Froldi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marco Froldi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anne Destrebecq
Department of Biomedical Science for Health, University of Milan, Via Pascal 32, 20133 Milan, Italy
1 shared publication - Elena Dozio
Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy
1 shared publication - Elena Vianello
Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy
1 shared publication - Emanuele Micaglio
Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, 20097 Milan, Italy
1 shared publication - Francesco Bandera
Clinical Cardiology, IRCCS Policlinico San Donato , Via Morandi 30, 20097 San Donato Milanese, Milan , Italy
1 shared publication - Gerd Schmitz
University Hospital Regensburg, Regensburg, Germany, Germany
1 shared publication
Latest Publications
- 19 June 2021
- Published by Taylor & Francis in Contemporary Nurse
- Vol. 57 (3-4) , 159-171
Nutritional care of older people: Investigating nurses’ attitudes in medical and surgical units
Malnutrition in older people in hospitals leads to negative outcomes for patients and to increased costs for the hospital. Nurses often underestimate the problem, showing negative attitudes.Aims: T...
- 19 June 2021
- Published by Taylor & Francis in Contemporary Nurse
- Vol. 57 (3-4) , 159-171
Nutritional care of older people: Investigating nurses’ attitudes in medical and surgical units
Malnutrition in older people in hospitals leads to negative outcomes for patients and to increased costs for the hospital. Nurses often underestimate the problem, showing negative attitudes.Aims: T...
- Open Access
- 14 January 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2) , 520
Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and Its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects
There is recent evidence that the dysfunctional responses of a peculiar visceral fat deposit known as epicardial adipose tissue (EAT) can directly promote cardiac enlargement in the case of obesity. Here, we observed a newer molecular pattern associated with LV dysfunction mediated by prostaglandin E2 (PGE2) deregulation in EAT in a cardiovascular disease (CVD) population. A series of 33 overweight CVD males were enrolled and their EAT thickness, LV mass, and volumes were measured by echocardiography. Blood, plasma, EAT, and SAT biopsies were collected for molecular and proteomic assays. Our data show that PGE2 biosynthetic enzyme (PTGES-2) correlates with echocardiographic parameters of LV enlargement: LV diameters, LV end diastolic volume, and LV masses. Moreover, PTGES-2 is directly associated with EPAC2 gene (r = 0.70, p < 0.0001), known as a molecular inducer of ST2/IL-33 mediators involved in maladaptive heart remodelling. Furthermore, PGE2 receptor 3 (PTEGER3) results are downregulated and its expression is inversely associated with ST2/IL-33 expression. Contrarily, PGE2 receptor 4 (PTGER4) is upregulated in EAT and directly correlates with ST2 molecular expression. Our data suggest that excessive body fatness can shift the EAT transcriptome to a pro-tissue remodelling profile, may be driven by PGE2 deregulation, with consequent promotion of EPAC2 and ST2 signalling.
- 14 January 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2) , 520
Open AccessCorrelative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and Its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects
There is recent evidence that the dysfunctional responses of a peculiar visceral fat deposit known as epicardial adipose tissue (EAT) can directly promote cardiac enlargement in the case of obesity. Here, we observed a newer molecular pattern associated with LV dysfunction mediated by prostaglandin E2 (PGE2) deregulation in EAT in a cardiovascular disease (CVD) population. A series of 33 overweight CVD males were enrolled and their EAT thickness, LV mass, and volumes were measured by echocardiography. Blood, plasma, EAT, and SAT biopsies were collected for molecular and proteomic assays. Our data show that PGE2 biosynthetic enzyme (PTGES-2) correlates with echocardiographic parameters of LV enlargement: LV diameters, LV end diastolic volume, and LV masses. Moreover, PTGES-2 is directly associated with EPAC2 gene (r = 0.70, p < 0.0001), known as a molecular inducer of ST2/IL-33 mediators involved in maladaptive heart remodelling. Furthermore, PGE2 receptor 3 (PTEGER3) results are downregulated and its expression is inversely associated with ST2/IL-33 expression. Contrarily, PGE2 receptor 4 (PTGER4) is upregulated in EAT and directly correlates with ST2 molecular expression. Our data suggest that excessive body fatness can shift the EAT transcriptome to a pro-tissue remodelling profile, may be driven by PGE2 deregulation, with consequent promotion of EPAC2 and ST2 signalling.